Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Caspase-4 is a human enzyme belonging to the caspase family of cysteine-aspartic acid proteases. It functions as an effector in the non-canonical inflammasome pathway, mediating LPS-induced pyroptosis. Upon activation by cytosolic LPS, it cleaves gasdermin-D and processes pro-inflammatory cytokines. It plays a critical role in innate immunity against Gram-negative bacterial infections, but dysregulation can contribute to pathological inflammation. It is primarily localized to the endoplasmic reticulum membrane. Inhibitors such as indoprofen are under investigation.
Inhibition of caspase-4 activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Caspase-4.